Paracetamol pro re nata orders: an audit

S A Lamb1, R L Henry

  • 1Royal Aberdeen Children's Hospital, Aberdeen, New South Wales, Australia.

Insights

Physician prescribing of paracetamol (acetaminophen) often lacks clear indications, leading to miscommunication with nurses and inconsistent administration. This highlights a systemic issue in hospital medication practices requiring clearer guidelines for effective pain management.

Area of Science:

  • Pediatric Pharmacology
  • Hospital Pharmacy Practice
  • Evidence-Based Medicine

Background:

  • Paracetamol (acetaminophen) is a common analgesic in hospitals.
  • Physician prescribing practices for paracetamol, particularly pro re nata (PRN), are not well understood.
  • Variability in prescribing and administration can impact patient care.

Purpose of the Study:

  • To compare physician prescribing habits for PRN paracetamol with nursing interpretation and evidence-based guidelines.
  • To identify discrepancies in the understanding and application of paracetamol orders.
  • To evaluate the clarity and consistency of paracetamol prescribing in pediatric care.

Main Methods:

  • Retrospective chart review of 313 children's records.
  • Audit of 100 children with PRN paracetamol orders to assess written indications.
  • Interviews with physicians and nurses regarding intended and actual administration of paracetamol.
  • Comparison of clinical practices with hospital guidelines.

Main Results:

  • Seventy-four percent of charts contained paracetamol orders.
  • Only one physician provided written indications for paracetamol administration.
  • Frequent miscommunications occurred between physicians and nurses regarding paracetamol orders.
  • Nurses administered paracetamol at lower temperatures than intended by physicians.
  • Significant variations in interpretation existed among healthcare professionals.

Conclusions:

  • Observed idiosyncratic ordering and administration of paracetamol suggests a systemic issue.
  • There is a need for more objective indications for paracetamol use.
  • Medical staff require clearer communication and explicit meaning in medication orders.
Abstract

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...